Expert consensus on clinical application of 177Lu-prostate specific membrane antigen radio-ligand therapy in prostate cancer
Journal Title: 中国临床医学(Chinese Journal of Clinical Medicine) - Year 2024, Vol 31, Issue 5
Abstract
177Lu- prostate specific membrane antigen (PSMA) radio-ligand therapy has been approved abroad for advanced prostate cancer and has been in several clinical trials in China. Based on domestic clinical practice and experimental data and referred to international experience and viewpoints, the expert group forms a consensus on the clinical application of 177Lu-PSMA radio-ligand therapy in prostate cancer to guide clinical practice.
Authors and Affiliations
Guobing LIU,Weihai ZHUO,Yushen GU,Zhi YANG,Yue CHEN,Wei FAN,Jianming GUO,Jian TAN,Xiaohua ZHU,Li HUO,Xiaoli LAN,Biao LI,Weibing MIAO,Shaoli SONG,Hao XU,Rong TIAN,Quanyong LUO,Feng WANG,Xuemei WANG,Aimin YANG,Dong DAI,Zhiyong DENG,Jinhua ZHAO,Xiaoliang CHEN,Yan FAN,Zairong GAO,Xingmin HAN,Ningyi JIANG,Anren KUANG,Yansong LIN,Fugeng LIU,Cen LOU,Xinhui SU,Lijun TANG,Hui WANG,Xinlu WANG,Fuzhou YANG,Hui YANG,Xinming ZHAO,Bo YANG,Xiaodong HUANG,Jiliang CHEN,Sijin LI,Jing WANG,Yaming LI,Hongcheng SHI,
Comparison of the efficacy of arthroscopically-assisted reduction and internal fixation combined with enhanced recovery after surgery and open reduction and internal fixation in the treatment of posterior lateral tibial plateau fractures
Objective To compare the clinical effects of arthroscopically-assisted reduction and internal fixation (ARIF) combined with enhanced recovery after surgery (ERAS) and open reduction and internal fixation surgery (ORIF) i...
The relationship between dietary fiber intake and hypertension: an analysis based on the NHANES data from 2015—2016 in the United States
ObjectiveTo explore the relationship between dietary fiber intake and hypertension in different populations. MethodsDietary fiber intake was calculated using the data from 2015—2016 National Health and Nutrition Examinat...
Expert consensus on clinical application of 177Lu-prostate specific membrane antigen radio-ligand therapy in prostate cancer
177Lu- prostate specific membrane antigen (PSMA) radio-ligand therapy has been approved abroad for advanced prostate cancer and has been in several clinical trials in China. Based on domestic clinical practice and experi...
Sex differences in the efficacy of first-line PD-1 blockade plus chemotherapy in patients with advanced lung adenocarcinoma
ObjectiveTo explore the impact of sex on the efficacy of first-line programmed death-1 (PD-1) blockade plus chemotherapy in patients with advanced lung adenocarcinoma and its potential biological mechanisms. MethodsThe c...
Predictive value of 3D quantitative shape features based on CT for disease-free survival of primary gastrointestinal stromal tumors
ObjectiveTo explore the predictive value of 3D quantitative shape features based on enhanced CT for disease-free survival (DFS) of primary gastric gastrointestinal stromal tumors (GIST) patients receiving curative resect...